Chinese strategy: Dr Reddy's outsources part manufacturing to local parties
Posted by
www.biotecnika.org
The company which won the tender to market Olanzapine drug in China,
is expected to launch it beginning next year, the official said. The
products are manufactured either in the plant owned by KRRP in China,
or partners in China, or in India by Dr. Reddy's, the official further
said.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/chinese-strategy-dr-reddys-outsources-part-manufacturing-to-local-parties/articleshow/72165363.cms
Subscribe to:
Post Comments (Atom)
Post a Comment